Trial Profile
Evaluation of the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ulimorelin in Subjects With Mild, Moderate and Severe Hepatic Impairment, in Comparison With Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ulimorelin (Primary)
- Indications Gastrointestinal disorders
- Focus Pharmacokinetics
- Sponsors Norgine
- 08 Dec 2014 New trial record